Key result
D.F.P. reduces mortality in irradiated rats, likely via anti-inflammatory effects on intestinal injury.
Why the study?
Does D.F.P. reduce mortality and intestinal injury in rats exposed to abdominal irradiation?
Does D.F.P. reduce mortality and intestinal injury in rats exposed to abdominal irradiation?
In a rat model, D.F.P. reduced mortality and exhibited anti-inflammatory effects on intestinal injury following acute abdominal irradiation.
Answers are grounded in this paper and cite their sources.
No change to radiotherapy practice; leaves open clinical translation of D.F.P. from rat intestinal protection models.
The administration of D.F.P. either before or up to 24 hours after abdominal irradiation reduced mortality after 1,050 and 1,334 r. D.F.P. had no effect on irradiation induced leucopenia nor on the later deaths (“bone-marrow death”) that occur after whole body irradiation. The effect of D.F.P. treatment on histological changes in the intestine has been studied. D.F.P. appears to have an anti-inflammatory action on radiation injury to the intestine. The mode of action of D.F.P. has been discussed and it is suggested that this drug might act by preventing the formation of vasoactive polypeptides (kallikrein and kinins).
No takes yet. Share an insight, caveat, or question.
D. A. Willoughby (1961) studied Acute Intestinal Radiation Syndrome. D.F.P. was evaluated on Mortality after 1,050 and 1,334 r abdominal irradiation. Administration of D.F.P. before or up to 24 hours after abdominal irradiation reduced mortality in rats, likely through an anti-inflammatory action on radiation injury to the intestine.
Synapse has enriched 10 related papers. Consider them for comparative context: